Medicare spending would increase $2.0 to $5.1 billion with lecanemab
May 18, 2023
$2.0 to $5.1 billion would include lecanemab and ancillary costs; estimated annual per-patient coinsurance could reach $6,636
Study identifies factors that predict driving cessation in seniors
May 22, 2024
Older age, female sex and progression to symptomatic Alzheimer’s disease were associated with driving cessation.
Long-term loneliness tied to risk for memory decline
Aug 08, 2022
The association was particularly strong for those aged 65 years or older and for women.
One in three Alzheimer’s, dementia cases tied to modifiable risk factors
May 11, 2022
Risk factors differ based on sex and race and ethnicity.
Flu vaccine tied to lower Alzheimer’s disease risk in older adults
Jul 26, 2022
Vaccination was associated with a 40% reduced risk for Alzheimer’s disease.
Dietary habits at midlife not tied to later risk for dementia
Oct 13, 2022
No links were seen between following conventional dietary recommendations or a modified Mediterranean diet at midlife and dementia and Alzheimer’s disease risks.
Benefit of thick liquids in Alzheimer’s disease and dysphagia unclear
May 06, 2024
Patients receiving thick versus thin liquids were less likely to be intubated and more likely to have respiratory complications.
Hypertension, type 2 diabetes contribute to brain changes in Puerto Rican seniors
Apr 01, 2022
A high prevalence of hypertension and type 2 diabetes was seen among the Puerto Rican cohort; those with both have deteriorating patterns in major white matter tracts.
Differences ID’d in tau burden in Down syndrome, Alzheimer’s disease
Apr 25, 2024
Differences in spatial distribution, timing and magnitude of tau burden were seen for two genetic forms of Alzheimer’s disease.
Study explores impact of FDA approval of aducanumab on trial participation
Dec 06, 2022
Individuals who were independently aware of the FDA decision demonstrated a reduced willingness to participate.